{
    "clinical_study": {
        "@rank": "131281", 
        "acronym": "VIRTUS", 
        "arm_group": {
            "arm_group_label": "Veniti Vici\u2122 Venous Stent System", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a multi-center, prospective, single arm, non-randomized study to evaluate safety and\n      efficacy of the Veniti Vici\u2122 Venous Stent System in relation to pre-defined Objective\n      Performance goals.  The follow-up period is 36 months."
        }, 
        "brief_title": "VIRTUS: An Evaluation of the Veniti Vici\u2122 Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction", 
        "completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Venous Disorder", 
            "Venous Outflow Obstruction", 
            "Symptomatic Venous Outflow Obstruction of Iliofemoral Vein"
        ], 
        "detailed_description": {
            "textblock": "The objective of this prospective study is to assess the safety and efficacy of the Veniti\n      Vici\u2122 Venous Stent System in achieving patency of the target venous lesion through 36 months\n      in patients with clinically significant chronic non-malignant obstruction of the iliofemoral\n      venous outflow tract."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age \u2265 18 years\n\n          -  Willing and capable of complying with all follow-up evaluations at the specified\n             times\n\n          -  Presence of unilateral, clinically significant, chronic non-malignant obstruction of\n             the common femoral vein, external iliac vein, common iliac vein, or any combination\n             thereof\n\n          -  Patient willing and able to provide informed consent.\n\n          -  Negative pregnancy test in females of child-bearing potential\n\n        Exclusion Criteria:\n\n          -  Presence or history of clinically significant pulmonary emboli within 6 months prior\n             to enrollment.\n\n          -  Venous obstruction that extends into the inferior vena cava (IVC)\n\n          -  Contralateral disease of the common femoral vein, external iliac vein, common iliac\n             vein, or any combination thereof with planned treatment within 30 days after subject\n             enrollment\n\n          -  Uncontrolled or active coagulopathy or known uncorrectable bleeding diathesis\n\n          -  Uncorrected hemoglobin of \u2264 9 g/dL\n\n          -  Intended concurrent thrombolysis or thrombectomy procedure OR intended or planned\n             (within 30 days) adjuvant procedure such as creation of temporary arteriovenous\n             fistula, placement of IVC filter, endovenectomy or saphenous vein ablation\n\n          -  Patients who have had any prior surgical or endovascular procedure of the target\n             vessel\n\n          -  Patients in whom the lesions cannot be traversed with a guide wire.\n\n          -  Female of childbearing potential who is pregnant or plans to become pregnant during\n             the duration of the clinical study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02112877", 
            "org_study_id": "STE-HUM-004P"
        }, 
        "intervention": {
            "arm_group_label": "Veniti Vici\u2122 Venous Stent System", 
            "intervention_name": "Veniti Vici\u2122 Venous Stent System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "iliofemoral vein", 
            "venous", 
            "venous obstruction"
        ], 
        "lastchanged_date": "April 10, 2014", 
        "location": [
            {
                "contact": {
                    "email": "collette.kirwan@nuigalway.ie", 
                    "last_name": "Collette Kirwan", 
                    "phone": "+353 91 494280"
                }, 
                "contact_backup": {
                    "email": "lisa.daly@nuigalway.ie", 
                    "last_name": "Lisa Daly", 
                    "phone": "+353 91 495892"
                }, 
                "facility": {
                    "address": {
                        "city": "Galway", 
                        "country": "Ireland"
                    }, 
                    "name": "Galway University Hospitals"
                }, 
                "investigator": {
                    "last_name": "Gerry O'Sullivan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ramirezortega75@gmail.com", 
                    "last_name": "Marta Ramirez Ortega, MD", 
                    "phone": "0034 619 20 79 22"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Madrid Monteprincipe y Torrelodones"
                }, 
                "investigator": {
                    "last_name": "Marta Ramirez Ortega, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Ireland", 
                "Spain"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "VIRTUS-OUS Safety and Efficacy of the Veniti Vici\u2122 Venous Stent System (Veniti, Inc.) When Used to Treat Clinically Significant Chronic Non-malignant Obstruction of the Iliofemoral Venous Segment", 
        "overall_official": [
            {
                "affiliation": "UNC Department of Surgery", 
                "last_name": "William Marston, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Vascular and Interventional Specialists of Orange County", 
                "last_name": "Mahmood Razavi, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Ireland: Irish Medicines Board", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Major Adverse Events within 30 days.", 
                "measure": "Primary Safety Endpoint", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "Primary patency rate", 
                "measure": "Primary Efficacy Endpoint", 
                "safety_issue": "No", 
                "time_frame": "12 months post-intervention"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02112877"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Veniti", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Veniti", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}